|
|
Article: Five Abstracts Related to VaxGen's Smallpox Vaccine to be Presented at ASM Biodefense Research Meeting.
- Article from:
- PR Newswire
- Article date:
- January 17, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BRISBANE, Calif., Jan. 17 /PRNewswire-FirstCall/ -- VaxGen, Inc. (Pink Sheets: VXGN.PK) announced today that five scientific abstracts related to its smallpox vaccine candidate, LC16m8, have been accepted to the February 15-18th, 2006 American Society of Microbiology (ASM) Biodefense Research Meeting in Washington, DC. Researchers will present clinical and pre-clinical data from studies entitled:
-- Safety and Immunogenicity of Attenuated Smallpox Vaccine, LC16m8:
Results from a Phase 2 Study
-- Clinical Evaluation of Attenuated Smallpox Vaccine LC16m8 in Japan
-- Attenuated Smallpox Vaccine LC16m8 Protects Mice from High-Dose Lethal
Intranasal ...